-
Hind.Aeronautics
4,294.00 5,675.00(%) -
Zomato Ltd
200.50 146.85(%) -
Aster DM Health.
504.00 558.30(%) -
Reliance Industr
1,269.05 1,156.00(%) -
Tata Motors
684.90 1,179.05(%) -
Jio Financial
232.25 394.70(%) -
Mazagon Dock
2,635.55 920.48(%) -
Vodafone Idea
6.77 6.60(%) -
HDFC Bank
1,836.40 1,880.00(%) -
Suzlon Energy
56.40 37.95(%) -
M & M
2,635.10 1,872.45(%) -
IDFC First Bank
54.63 52.60(%) -
Dixon Technolog.
13,019.00 7,100.05(%) -
I R F C
123.65 108.05(%) -
Bharat Electron
306.50 340.35(%) -
Adani Energy Sol
863.60 588.25(%) -
Asian Paints
2,322.35 2,125.00(%) -
Reliance Power
44.75 54.25(%) -
Hindustan Copper
218.75 195.35(%) -
IndusInd Bank
643.70 605.40(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Zim Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 4284.0
- ISIN : INE518E01015
-
Today’s Low
80.00 -
Today’s High
85.29

-
Open
82.20 -
Perv Close
81.89 -
52W Low
79.49 -
52W High
131.40
Key Indicators
-
P/E(TTM)
27.47
-
Mar.Cap (₹Cr.)
392.39
-
Div & Yield %
0.00
-
Book Value(₹)
48.10
-
Debt-Equity Ratio
-1.66
-
AGM Date
28-Mar-2025
-
EPS
2.92
-
P/E Ratio
27.47
Financials Ratios
-
Debt-Equity Ratio
0.40
-
Mar.Cap (₹Cr.)
392.39
-
RONW (%)
7.86
-
ROCE (%)
9.97
Score Board
-
Equity (₹ in Cr.)
48.73
-
BV (₹)
48.10
-
Sales( ₹ in Cr.)
365.47
-
NP (in Cr.)
16.77
-
NP Var(%)
-33.0
-
Div%
0.0
-
CPS (₹)
6.50
-
EPS (₹)
3.40
-
Traded Value (₹ in Lakhs)
390.78
-
52 Week High
131.40
-
52 Week Low
79.49
-
Price BSE
80.0
-
Price NSE
81.00
-
Market Capital( in Cr.)
390.78
-
P/C Ratio
12.30
-
P/E Ratio
23.20
-
Price Vs.BV
3.40
-
20-Mar-2025( 12:53)
Hot Pursuit - Zim L... - <P> This authorization from IN...
-
11-Feb-2025( 08:05)
Results - Announcements - Zim L... - Net profit of Zim Laboratories...
-
04-Feb-2025( 03:18)
Corporate News - Zim L... - Zim Laboratories will hold a m...
-
11-Jan-2025( 09:56)
Corporate News - ZIM L... - ZIM Laboratories and Neuraxpha...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
---|---|---|---|---|---|---|
Sales Turnover | 365.47 | 396.53 | 329.49 | 303.63 | 274.32 | 331.72 |
Excise Duty | 353.56 | 386.73 | 324.31 | 288.33 | 257.80 | 322.74 |
Net Sales | 365.47 | 396.53 | 329.49 | 303.63 | 274.32 | 331.72 |
Other Income | 4.69 | 6.43 | 4.51 | 2.45 | 4.66 | 2.05 |
Stock Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Income | 370.16 | 402.96 | 334.00 | 306.08 | 278.98 | 333.77 |
EXPENDITURE : | ||||||
Raw Materials | 353.56 | 386.73 | 324.31 | 288.33 | 257.80 | 322.74 |
Power & Fuel Cost | 353.56 | 386.73 | 324.31 | 288.33 | 257.80 | 322.74 |
Employee Cost | 50.81 | 46.47 | 38.63 | 34.48 | 34.58 | 48.14 |
Other Manufacturing Expenses | 6.03 | 5.95 | 5.24 | 3.94 | 6.01 | 4.54 |
Selling & Administrative Expenses | 51.66 | 55.69 | 54.44 | 43.70 | 40.96 | 63.26 |
Miscellaneous Expenses | 6.03 | 5.95 | 5.24 | 3.94 | 6.01 | 4.54 |
Less : Pre-operative Expenses Capitalised : | ||||||
Total Expenditure | 347.12 | 367.04 | 314.70 | 292.32 | 280.46 | 311.03 |
Operating Profit | 45.43 | 38.38 | 32.90 | 26.06 | 29.84 | 13.85 |
Interest | 6.92 | 5.58 | 8.31 | 10.89 | 12.65 | 10.59 |
Gross Profit | 23.04 | 35.92 | 19.30 | 8.58 | -1.49 | 22.74 |
Depreciation | 14.83 | 16.13 | 14.84 | 14.61 | 13.27 | 11.14 |
Profit Before Tax | 23.04 | 35.92 | 19.30 | 8.58 | -1.49 | 22.74 |
Tax | 0.77 | 6.28 | 3.40 | 0.01 | 0.00 | 4.80 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 5.45 | 4.63 | 2.88 | 2.95 | -3.10 | 1.82 |
Reported Net Profit | 16.76 | 25.01 | 13.01 | 5.62 | 1.74 | 16.01 |
Extraordinary Items | 23.04 | 35.92 | 19.30 | 8.58 | -1.49 | 22.74 |
Adjusted Net Profit | 16.76 | 25.01 | 13.01 | 5.62 | 1.74 | 16.01 |
Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P & L Balance brought forward | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.81 |
P & L Balance carried down | 16.76 | 25.01 | 13.01 | 5.62 | 1.74 | 16.01 |
Dividend | - | - | - | - | - | - |
Preference Dividend | - | - | - | - | - | - |
Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.00 |
Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.50 |
Earnings Per Share-Unit Curr | 3.44 | 5.13 | 2.67 | 3.46 | 1.07 | 9.93 |
Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.81 |
Book Value(Adj)-Unit Curr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.81 |